Harrow, Inc. (HROW)
36.13
-3.09
(-7.88%)
USD |
NASDAQ |
Mar 05, 16:00
36.54
+0.41
(+1.13%)
After-Hours: 20:00
Harrow Cash from Investing (Quarterly) : -4.73M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -11.84M |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Xeris Biopharma Holdings, Inc. | -0.333M |
| Stoke Therapeutics, Inc. | 9.094M |
| Vir Biotechnology, Inc. | 86.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.411M |
| Cash from Financing (Quarterly) | -5.044M |
| Free Cash Flow | 42.76M |
| Free Cash Flow Per Share (Quarterly) | 0.2159 |
| Free Cash Flow to Equity (Quarterly) | 7.935M |
| Free Cash Flow to Firm (Quarterly) | 11.34M |
| Free Cash Flow Yield | 3.14% |